Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease

Journal of Digestive Diseases

Volumn 11, Issue 2, 2010, Pages 94-100

  Duan, Xiao Yan ^a   Zhao, He Ping ^b   Fan, Jian Gao ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Fatty liver; Non alcoholic steatohepatitis; Oxidative stress; Rats; RT PCR; Thioredoxin

Indexed keywords

CHOLESTEROL; EOSIN; FATTY ACID; GLUTATHIONE; HEMATOXYLIN; MALONALDEHYDE; MESSENGER RNA; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; HISTOPATHOLOGY; LIPID DIET; MALE; MOLECULAR DYNAMICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DISEASE MODEL; FATTY LIVER; LIVER; METABOLISM; PATHOLOGY; WISTAR RAT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHOLESTEROL; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; GLUTATHIONE; LIVER; MALE; MALONDIALDEHYDE; RATS; RATS, WISTAR; RNA, MESSENGER; SUPEROXIDE DISMUTASE; THIOREDOXINS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954703376     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2010.00422.x     Document Type: Article

References (19)

1. Zeng MD, Fan JG, Lu LG. Chinese National Consensus Workshop on Nonalcoholic Fatty Liver Disease. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis 2008, 9:108-12.
2. Koháryová M, Kolárová M. Oxidative stress and thioredoxin system. Gen Physiol Biophys 2008, 27:71-84.
3. Huang YL, Chuang CY, Sung FC, Chen CY. Thioredoxin overexpression modulates remodeling factors in stress responses to cigarette smoke. J Toxicol Environ Health A 2008, 71:1490-8.
4. Andoh T, Chock PB, Chiueh CC. The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J Biol Chem 2002, 277:9655-60.
5. Yegorova S, Yegorov O, Lou MF. Thioredoxin induced antioxidant gene expression in human lens epithelial cells. Exp Eye Res 2006, 83:783-92.
6. Mitsuyoshi H, Yasui K, Harano Y. Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol Res 2008, 11:1-8.
7. Kim YC, Masutani H, Yamaguchi Y, Itoh K, Yamamoto M, Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. Biol Chem 2001, 276:18399-406.
8. Li LB, Liu GT. Biology of thioredoxin and its association with Alzheimer's Disease and Parkinson's Disease. Yao Xue Xue Bao 2008, 43:1-8.
9. Munemasa Y, Kim SH, Ahn JH, Kwong JM, Caprioli J, Piri N. Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress. Invest Ophthalmol Vis Sci 2008, 49:3535-43.
10. Wu XW, Teng ZY, Jiang LH. Human thioredoxin exerts cardioprotective effect and attenuates reperfusion injury in rats partially via inhibiting apoptosis. Chin Med J (Engl) 2008, 121:819-26.
11. Tao L, Gao E, Bryan NS. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation. Proc Natl Acad Sci U S A 2004, 101:11471-6.
12. Okuyama H, Nakumura H, Shimahara Y. Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology 2003, 37:1015-25.
13. Okuyama H, Nakamura H, Shimahara Y. Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. J Hepatology 2005, 42:117-23.
14. Tsutsui T, Koide H, Fukahori H. Adenoviral transfection of hepatocytes with the thioredoxin gene confers protection against apoptosis and necrosis. Biochem Biophys Res Commun 2003, 307:765-70.
15. Mukherjee A, Martin SG. The thioredoxin system: a key target in tumour and endothelial cells. Br J Radiol 2008, 81:S57-68.
16. Okuyama H, Son A, Ahsan MK, Masutani H, Nakamura H, Yodoi J. Thioredoxin and thioredoxin binding protein 2 in the liver. IUBMB Life 2008, 60:656-60.
17. Sumida Y, Nakashima T, Yoh T. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol 2003, 38:32-8.
18. Nakashima T, Sumida Y, Furutani M. Elevation of serum thioredoxin levels in patients with nonalcoholic steatohepatitis. Hepatol Res 2005, 33:135-7.
19. Grattagliano I, Caraceni P, Calamita G. Severe liver steatosis correlates with nitrosative and oxidative stress in rats. Eur J Clin Invest 2008, 38:523-30.